On Thursday, Moderna ($MRNA@US) announced that its COVID-19 vaccine booster shot produced a “robust” antibody response to the Delta Variant. The Delta Variant is a more contagious and dangerous variant of the original strain that swept the world in early 2020. Shares of Moderna are up 0.